Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
hyaluronic acid
Medication labelWhy this: Advisory · dailymed-otc
Hyaluronic acid freeze-dried powder is a skin care product that mainly replenishes water and repairs, and is widely used to improve a variety of skin problems. The following are its main indications: 1. Dehydrated skin Symptoms: The skin is dry, rough, and tight, and even peeling occurs. Functions: Hyaluronic acid freeze-dried powder can deeply replenish water, enhance the skin's moisturizing ability, and relieve dryness symptoms. 2. Damaged skin barrier Symptoms: Skin is sensitive, red, swollen, and easily inflamed, and even tingling occurs, and the barrier function is weakened. Functions: Repair the skin barrier, promote the repair and regeneration of damaged skin, and improve the sensitive state. 3. Early fine lines and dry lines Symptoms: Dry lines and superficial fine lines at the corners of the eyes and mouth caused by water loss. Functions: Replenish skin moisture, improve fine lines caused by dryness, and make the skin look smoother and more elastic. 4. Dull and dull skin Symptoms: The skin is rough, lacks luster, and looks tired. Functions: Improve skin moisture, improve dullness, and restore skin translucency. 5. Skin with acne and acne marks Symptoms: Pigmentation and acne marks are left after acne heals, or the skin's ability to repair is weak. Function: Accelerates acne repair, helps fade acne marks, and promotes skin self-repair. 6. Sensitive skin Symptoms: Strong reaction to external stimuli (such as wind, temperature difference), prone to redness and fever. Function: Calms and soothes the skin, reduces irritation, and enhances skin tolerance. 7. Early aging skin Symptoms: Sagging and dry skin accompanied by loss of collagen, showing signs of aging. Function: Replenishes moisture and locks in moisture, while maintaining skin elasticity and delaying skin aging.
- generic_name
- hyaluronic acid
- product_names
- Hyaluronic acid
- ndc
- 84775-063, 84775-063-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en